| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |